Author

Masumi Miyake

Institution: AYUMI Pharmaceutical Corporation (Japan)

Observed institution: AYUMI Pharmaceutical Corporation (Japan)

ORCID: 0000-0002-9021-8040

Observed ORCID: 0000-0002-9021-8040

OpenAlex ID: A5019181787

Protocol for the RETHINK study: a randomised, double-blind, parallel-group, non-inferiority clinical trial comparing acetaminophen and NSAIDs for treatment of chronic pain in elderly patients with osteoarthritis of the hip and knee

2023 · Makoto Endo, Shinya Kawahara, et al. · BMJ Open · 6

Real‐World Hepatic Safety of Oral Acetaminophen Versus Loxoprofen/Celecoxib: Using a Nationwide Electronic Medical Record Database

2023 · Yasuyuki Okumura, Takeshi Kimura, et al. · The Journal of Clinical Pharmacology · 4

Comparison of the efficacy and safety of acetaminophen versus NSAIDs for the treatment of chronic pain in older adults with osteoarthritis of the hip and knee: Findings from the randomized, double-blind, parallel-group, non-inferiority RETHINK study

2026 · Makoto Endo, Tsutomu Kawano, et al. · Osteoarthritis and Cartilage Open

Works count: 3

Citation count: 10

H-index: 2

I10-index: